Clinarc SRL
The score of Clinarc shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Clinarc's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 69,805 € | ||||
| Equity | 306,406 € | ||||
| Cash | 103,095 € | ||||
| EBITDA | 122,075 € | ||||
| Total assets | 351,723 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 27 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Clinarc's financial analysis
- Solvency87.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Clinarc
Clinarc's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.870.140
- VAT number
- BE0473870140
- Peppol
- Registered · 0208:0473870140 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Jan 2001
- Registered office
- 1730 Asse
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Clinarc (SRL) has been based in Asse since 2001, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 69,805 € and equity of 306,406 €; its revenue is not published. Its solvency stands at 87.1%, above the median of its sector (60.4%).
Companies similar to Clinarc
Companies in the same business, of comparable size and area, outside its group.
- Autonomycs Research and experimental development on natural sciences and engineering Asse · balance sheet 413,442 €
- Galaxies Research and experimental development on natural sciences and engineering Chaumont-Gistoux · balance sheet 333,089 €
- VDW Consults Research and experimental development on natural sciences and engineering Kampenhout · balance sheet 220,025 €
- Roger Research and experimental development on natural sciences and engineering Lasne · balance sheet 151,258 €
- Dr. Stefanie Vanderbauwhede Research and experimental development on natural sciences and engineering Kortrijk · balance sheet 355,078 €
- Sicher Research and experimental development on natural sciences and engineering Balen · balance sheet 246,186 €
- BGO onderzoek en onderwijs Research and experimental development on natural sciences and engineering Antwerp · balance sheet 296,350 €
- Cardio Gold Consulting Other human health activities n.e.c. Waterloo · balance sheet 92,333 €
Frequently asked questions about Clinarc
What is the revenue of Clinarc?
Clinarc files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Clinarc?
In Belgium, the VAT number is the company number prefixed with BE: BE0473870140 for Clinarc, if the company is VAT-registered. Its company number (CBE) is 0473.870.140.
Where is the registered office of Clinarc?
According to the CBE register, the registered office of Clinarc is in 1730 Asse.
What is the equity of Clinarc?
At the close of the 2025 financial year, the equity of Clinarc amounts to 306,406 €, a solvency of 87.1% of total assets.
Who manages Clinarc?
The register lists 1 active mandates at Clinarc. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Clinarc
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →